Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: Mid-season analysis 2010/11

Eurosurveillance

Volumn 16, Issue 6, 2011, Pages

  Pebody, R ^a   Hardelid, P ^a   Fleming, D M ^b   McMenamin, J ^c   Andrews, N ^a   Robertson, C ^c,d   Thomas, D R ^e   Sebastianpillai, P ^a   Ellis, J ^a   Carman, W ^f   Wreghitt, T ^a   Zambon, M ^a   Watson, J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e PUBLIC HEALTH WALES   (United Kingdom)

^f West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA B; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEASONAL INFLUENZA; SEASONAL VARIATION; SENSITIVITY ANALYSIS; THROAT CULTURE; UNITED KINGDOM;

EID: 79951593014     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wichmann O, Stöcker P, Poggensee G, Altmann D, Walter D, Hellenbrand W, Krause G, Eckmanns T. Pandemic influenza A(H1N1) 2009 breakthrough infections and estimatesof vaccine effectiveness in Germany 2009-2010. Euro Surveill. 2010; 15(18):pii=19561. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19561.
2. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: Results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med. 2011; 8(1):e1000388
3. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii=19763. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763
4. Health Protection Agency. Department of Health. Pandemic influenza vaccine uptake amongst patient groups in primary in England 2009-10. Available from: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_121014.pdf
5. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y et al. Estimating vaccine effectiveness against laboratoryconfirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 2007;25(15):2842-51.
6. Fleming DM, Andrews NJ, Elllis JS, Bermingham A, Sebastianpillai P, Elliot AJ et al. Estimating Influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062-7
7. Gunson R, Maclean A, Davies E, Bennett S, Miller R, Carman WF. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods. 2010;163(2):258-61.
8. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, Brown D. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 2009; 14(22):pii=19230. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19230.
9. Ferdinands JM, Belongia EA, Nwasike C, Shay DK. Influenza vaccination status is not associated with influenza testing among children: Implications for observational studies of vaccine effectiveness. Vaccine. 2011. [Epub ahead of print]
10. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-31.
11. Hardelid P, Andrews N, Hoschler K, Stanford E, Baguelin M, Waight P et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009. Health Technol Assess. 2010;14(55):115-92.